FDA Shares Its Thinking on Drug-Drug Interaction Studies

By Sam | January 23, 2020

The FDA released two final guidances yesterday outlining the agency’s approach to drug-drug interaction (DDI) studies for DDIs mediated by cytochrome P450 (CYP) enzymes and transporters.
Source: Drug Industry Daily

Posted in Drug Industry Daily